SCHEMBL6840706

SCHEMBL6840706

CCCCOC(=O)[C@H]1C=C[C@@H](NC(C)=O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.40
RECQL P46063 1/20 0.40
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ASGR1 P07306 1/20 0.37
TSHR P16473 3/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ESR1 P03372 1/20 0.36
CYP2D6 P10635 1/20 0.36
NR1H2 P55055 1/20 0.36
RNASEL Q05823 1/20 0.36
ATM Q13315 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6841385 0.91 ALDH1A1 (0.35) ALDH1A1KDM4EASGR1TSHRSMN1; SMN2
SCHEMBL6841531 0.91 ALDH1A1 (0.35) ALDH1A1KDM4EASGR1TSHRSMN1; SMN2
SCHEMBL6836198 0.84 NFKB1 (0.39) ALDH1A1HPGDKDM4ELMNASMN1; SMN2
SCHEMBL6836199 0.84 NFKB1 (0.39) ALDH1A1HPGDKDM4ELMNASMN1; SMN2
SCHEMBL14475704 0.84 NFKB1 (0.43) ALDH1A1HPGDRECQLMAPK1L3MBTL1
SCHEMBL14475702 0.80 ALDH1A1 (0.44) ALDH1A1HPGDRECQLMAPK1L3MBTL1
SCHEMBL7862552 0.80 HPGD (0.39) ALDH1A1HPGDRECQLMAPK1ASGR1
SCHEMBL6818575 0.80 HPGD (0.39) ALDH1A1HPGDRECQLMAPK1ASGR1
SCHEMBL6841691 0.79 CYP1A2 (0.35) ALDH1A1KDM4ETSHRCYP1A2CYP2C19
SCHEMBL8893825 0.79 CYP1A2 (0.35) ALDH1A1KDM4ETSHRCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167351-A1 Method for preparing (1R,4S)-2-azabicyclo[2.2.1]hept-5-ene-3-one derivatives BERNEGGER-EGLI CHRISTINE (CH) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167351-A1 Method for preparing (1R,4S)-2-azabicyclo[2.2.1]hept-5-ene-3-one derivatives APEH, CYP51A1, CYP8B1 ALDH1A1 212/4885HPGD 273/4885RECQL 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.